Clinical Research Directory

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

Sponsor: M.D. Anderson Cancer Center

Summary

This clinical trial identifies factors associated with completing genetic testing, aids in the development of a decision support tool, and tests how well the decision support tool works to enhance germline genetic testing in patients with prostate cancer. Germline genetic testing is a guideline-recommended standard of care for many patients with prostate cancer. Completing genetic testing can enable the use of targeted therapies, offers access to novel clinical trials, provides valuable information, and can help identify at risk family members. The decision support tool may educate patients and assist in the decision to engage with germline genetic testing.

Official title: Efforts to Enhance Germline Genetic Testing at Lyndon B. Johnson Hospital

Key Details

Conditions

Interventions

Locations (1)